This journal has not published any issues.

Impact Factor 2025

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

The eternal enigma in prostatic biopsy access route

Andrea Fabiani, Emanuele Principi, Alessandra Filosa, Lucilla Servi

245-246

03-10-2017

https://doi.org/10.4081/aiua.2017.3.245

2466

Downloads: 1540
Predictive value of PSA density in the diagnosis of prostate cancer in lebanese men

Ali Msheik, Mohamed Mohanna, Ali Mhanna, Ali Kanj, Mohamad Moussa, Assaad Mohanna

18-24

28-03-2022

https://doi.org/10.4081/aiua.2022.1.18

1342

Downloads: 952
A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer

Carmelo Agostino Di Franco, Hussein Jallous, Daniele Porru, Giovanni Luca Giliberto, Tiziano Cebrelli, Carmine Tinelli, Bruno Rovereto

55-59

31-03-2017

https://doi.org/10.4081/aiua.2017.1.55

3384

Downloads: 2172
“In-bore” MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation

Angelo Porreca, Daniele D'Agostino, Mario Vigo, Paolo Corsi, Daniele Romagnoli, Alessandro Del Rosso, Riccardo Schiavina, Eugenio Brunocilla, Walter Artibani, Marco Giampaoli

224-229

14-01-2020

https://doi.org/10.4081/aiua.2019.4.224

1634

Downloads: 885
The relationship of prostate cancer diagnosed by magnetic resonance imaging/transrectal ultrasound prostate fusion biopsy with standard and adjusted anogenital distances

Feyzi Sinan Erdal, Akif Erbin, Sami Sekkeli, Caglar Dizdaroglu, Rustu Turkay

26-06-2026

https://doi.org/10.4081/aiua.2026.15162

348

Downloads: 246
Role of sterile pyuria in association to elevated PSA values in the diagnosis of non-palpable prostate cancer?

Selamettin Demir

02-10-2019

https://doi.org/10.4081/aiua.2019.3.167

2033

Downloads: 1402
Chronic inflammation of the prostate type IV with respect to risk of prostate cancer

Antonio B. Porcaro, Emanuele Rubilotta, Aldo Petrozziello, Claudio Ghimenton, Filippo Migliorini, Stefano Zecchini Antoniolli, Vincenzo Lacola, Carmelo Monaco, Pierpaolo Curti, Stefano Cavalleri, Romeo Pianon, Walter Artibani

208-211

30-09-2014

https://doi.org/10.4081/aiua.2014.3.208

2954

Downloads: 1802
Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer

Sinan Avci, Efe Onen, Volkan Caglayan, Metin Kilic, Murat Sambel, Sedat Oner

1-6

06-04-2020

https://doi.org/10.4081/aiua.2020.1.1

1681

Downloads: 1469
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation

Andrea B. Galosi, Guevar Maselli, Giulia Sbrollini, Gaetano Donatelli, Lorenzo Montesi, Matteo Tallè, Rodolfo Montironi

292-295

30-12-2016

https://doi.org/10.4081/aiua.2016.4.292

2616

Downloads: 1555
Genetic determinants of prostate cancer predisposition in Ashkenazi Jews

Gianpaolo Perletti, Daniel Cohen Hattab, Sergio DellaPergola, Ofer Gofrit, Vittorio Magri, Alberto Trinchieri

12-06-2025

https://doi.org/10.4081/aiua.2025.13762

1007

Downloads: 619
Revolutionizing localized prostate cancer treatment: Stereotactic radiotherapy “Moroccan experience”

Asmâa Naim, Zineb Lahlou, Othmane Kaanouch, Abdelajalil Heddat, Safae Mansouri

16-02-2024

https://doi.org/10.4081/aiua.2024.12104

853

Downloads: 664
Sexual activity and the risk of prostate cancer: Review article

Ahmed Fouad Kotb, Ahmad Beltagy, Asmaa Mohamed Ismail, Mohamed Mohie Hashad

214-215

30-09-2015

https://doi.org/10.4081/aiua.2015.3.214

8160

Downloads: 3658
Association of metabolic syndrome with prostate cancer diagnosis and aggressiveness in patients undergoing transrectal prostate biopsy

Charalampos Fragkoulis, Ioannis Glykas, Lazaros Tzelves, Konstantinos Stasinopoulos, Lazaros Lazarou, Andreas Kaoukis, Athanasios Dellis, Georgios Stathouros, Georgios Papadopoulos, Konstantinos Ntoumas

291-295

30-09-2021

https://doi.org/10.4081/aiua.2021.3.291

1270

Downloads: 832
Diagnostic performance of PI-RADS and PSA density for detecting clinically significant prostate cancer

Walid Shanaa, Ibrahim Alnadhari, Omar Ali, Osama Abdeljaleel, Hana J. Abukhadijah, Ahmad Shamsodini

29-06-2026

https://doi.org/10.4081/aiua.2026.15133

388

Downloads: 274
Association between large prostate calculi and prostate cancer

Cem Yucel, Salih Budak

181-183

30-09-2018

https://doi.org/10.4081/aiua.2018.3.181

1795

Downloads: 840
What is the correct staging and treatment strategy for locally advanced prostate cancer extending to the bladder?

Özgür Haki Yüksel, Ayhan Verit, Ahmet Ürkmez

130-135

07-07-2015

https://doi.org/10.4081/aiua.2015.2.130

2604

Downloads: 1268
MRI/US fusion prostate biopsy: Our initial experience

Vito Lacetera, Bernardo Cervelli, Antonio Cicetti, Giuliana Gabrielloni, Michele Montesi, Roberto Morcellini, Gianni Parri, Emilio Recanatini, Gianluca Giglioni, Andrea Benedetto Galosi, Valerio Beatrici

296-299

30-12-2016

https://doi.org/10.4081/aiua.2016.4.296

3255

Downloads: 1638
Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis

Lucio Dell’Atti

76-79

31-03-2015

https://doi.org/10.4081/aiua.2015.1.76

1964

Downloads: 1185
Anti-cancer activity of Ajwa dates extract (Phoenix Dactylifera L.) through analysis of MCL-1 levels, EGFR, and p53 expressions on apoptosis in human prostate cancer cell lines PC3: an in vitro study

Abdul Azis, Andi Asadul Islam, Haerani Rasyid, Ika Yustisia, Lukman Hakim, Syakib Bakri, Agussalim Bukhari, Andi Alfian Zainuddin

04-08-2025

https://doi.org/10.4081/aiua.2025.14027

746

Downloads: 539
Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?

Sara Teixeira Anacleto, Joana Neves Alberto, Emanuel Carvalho Dias, Pedro Sousa Passos, Mário Cerqueira Alves

32-36

28-03-2022

https://doi.org/10.4081/aiua.2022.1.32

1214

Downloads: 713
Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer

Ana Marta Ferreira, Roberto Jarimba, André Rego, João Gama, Rui Almeida, Miguel Eliseu, Vasco Quaresma, Pedro Nunes, Vitor Sousa, Arnaldo Figueiredo

31-03-2026

https://doi.org/10.4081/aiua.2026.14731

397

Downloads: 293
Assesment of anogenital distance as a marker in diagnosis of prostate cancer

Aytac Sahin, Musab Ali Kutluhan, Tuncay Toprak, Yasin Vural, Ahmet Ürkmez, Serkan Akan, Ayhan Verit

02-10-2019

https://doi.org/10.4081/aiua.2019.3.163

2320

Downloads: 1152
Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform

Giuseppe Albino, Francesca Vendittelli, Carmela Paolillo, Cecilia Zuppi, Ettore Capoluongo

164-169

31-12-2013

https://doi.org/10.4081/aiua.2013.4.164

2447

Downloads: 2242
Diagnostic assessment program for prostate cancer: Lessons learned after 2 years and degree of compliance to Canadian guidelines

Waleed Shabana, Ahmed Kotb, Daniel Tesolin, Mohammed F.K. Ibrahim, Kristi Dolcetti, Amy Boucher, Mohammed Bassuony, Kevin Ramchandar, Ahmed S. Zakaria, Hazem Elmansy, Walid Shahrour

389-392

20-12-2021

https://doi.org/10.4081/aiua.2021.4.389

1758

Downloads: 691
Cryotherapy for low risk prostate cancer, oncological and functional medium term outcomes: A three center prospective study

Valerian Ciprian Lucan, Franco Lugnani, Salvatore Butticè, Emre Sener, Christopher Netsch, Michele Talso, Francesco Cantiello, Rosa Pappalardo, Carlo Magno

97-101

30-06-2017

https://doi.org/10.4081/aiua.2017.2.97

2383

Downloads: 1407
Outcomes of active surveillance for clinically localized prostate cancer in a middle eastern tertiary care center

Mohammad Hout, Ali Merhe, Nassib Abou Heidar, Jose M. El-Asmar, Wassim Wazzan, Bassel Bachir, Rola Jaafar, Albert El-Hajj, Muhammad Bulbul

385-388

20-12-2021

https://doi.org/10.4081/aiua.2021.4.385

1542

Downloads: 681
Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer

Pietro Pepe, Ludovica Pepe, Maria Tamburo, Giulia Marletta, Michele Pennisi, Filippo Fraggetta

274-277

26-09-2022

https://doi.org/10.4081/aiua.2022.3.274

2980

Downloads: 1452
Morbidity following transperineal prostate biopsy: Our experience in 8.500 men

Pietro Pepe, Michele Pennisi

155-159

29-06-2022

https://doi.org/10.4081/aiua.2022.2.155

1960

Downloads: 1171
Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective study

Roberto Saldanha Jarimba, Miguel Nobre Eliseu, João Pedroso Lima, Vasco Quaresma, Pedro Moreira, Pedro Coelho Nunes, Edgar Tavares da Silva, Arnaldo José Figueiredo

393-398

20-12-2021

https://doi.org/10.4081/aiua.2021.4.393

1977

Downloads: 1429
Relugolix in treatment of prostate cancer: a review

Ioannis Kyriazis, Themistoklis Bellos, Stamatios Katsimperis, Panagiotis Angelopoulos, Panagiotis Neofytoy, Ioannis Varkarakis, Andreas Skolarikos, Athanasios Papatsoris

13-11-2025

https://doi.org/10.4081/aiua.2025.14277

1375

Downloads: 753
Impact of statins on metastatic castration-resistant prostate cancer patients receiving new hormonal agents

Ana Marta Ferreira, Tiago Sousa, Roberto Jarimba, Vasco Quaresma, Pedro Nunes, Edgar Tavares da Silva, Arnaldo Figueiredo

03-11-2025

https://doi.org/10.4081/aiua.2025.14179

1071

Downloads: 590
Green tea catechins for chemoprevention of prostate cancer in patients with histologically-proven HG-PIN or ASAP. Concise review and meta-analysis

Gianpaolo Perletti, Vittorio Magri, Anne Vral, Konstantinos Stamatiou, Alberto Trinchieri

02-10-2019

https://doi.org/10.4081/aiua.2019.3.153

3618

Downloads: 2161
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer

Arrigo F.G. Cicero, Olta Allkanjari, Gian Maria Busetto, Tommaso Cai, Gaetano Larganà, Vittorio Magri, Gianpaolo Perletti, Francesco Saverio Robustelli Della Cuna, Giorgio Ivan Russo, Kostantinos Stamatiou, Alberto Trinchieri, Annabella Vitalone

02-10-2019

https://doi.org/10.4081/aiua.2019.3.139

36006

Downloads: 17099
Repeated biopsy in the detection of prostate cancer: When and how many cores

Vincenzo Scattoni, Andrea Russo, Ettore Di Trapani, Umberto Capitanio, Giovanni La Croce, Francesco Montorsi

311-313

30-12-2014

https://doi.org/10.4081/aiua.2014.4.311

2816

Downloads: 1635
The pathological and clinical features of anterior lesions of prostate cancer: Evaluation in a single cohort of patients

Daniele D'Agostino, Paolo Corsi, Michele Colicchia, Daniele Romagnoli, Gian Maria Busetto, Matteo Ferro, Alessandro Tafuri, Matteo Cevenini, Federico Mineo Bianchi, Marco Giampaoli, Angelo Porreca

23-06-2020

https://doi.org/10.4081/aiua.2020.2.102

1503

Downloads: 965
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy

Antonio B. Porcaro, Beatrice Caruso, Alessandro Terrin, Nicolò De Luyk, Giovanni Cacciamani, Paolo Corsi, Davide Inverardi, Davide De Marchi, Roberto Baldassarre, Mariangela Cerruto, Claudio Ghimenton, Matteo Brunelli, Stefano Zecchini Antoniolli, Aldo Petrozziello, Walter Artibani

17-22

31-03-2016

https://doi.org/10.4081/aiua.2016.1.17

2378

Downloads: 1668
Safety and tolerability of biodegradable balloon spacers in patients undergoing radiotherapy for organ-confined prostate cancer

Luca Topazio, Federico Narcisi, Fabio Tana, Cosimo Ciotta, Vincenzo Iossa, Pasquale Perna, Francesco Chiaramonti, Federico Romantini

13-06-2023

https://doi.org/10.4081/aiua.2023.11156

1247

Downloads: 900
Effect on prostatic specific antigen by a short time treatment with a Curcuma extract: A real life experience and implications for prostate biopsy

Andrea Fabiani, Carolina Morosetti, Alessandra Filosa, Emanuele Principi, Luca Lepri, Valentina Maurelli, Fabrizio Fioretti, Lucilla Servi

107-111

30-06-2018

https://doi.org/10.4081/aiua.2018.2.107

2866

Downloads: 1135
The presence of chronic inflammation in positive prostate biopsy is associated with upgrading in radical prostatectomy

Ekrem Guner, Yavuz Onur Danacioglu, Yusuf Arikan, Kamil Gokhan Seker, Salih Polat, Halil Firat Baytekin, Abdulmuttalip Simsek

280-284

30-09-2021

https://doi.org/10.4081/aiua.2021.3.280

1473

Downloads: 813
Prostate volume effect on Gleason score upgrading in active surveillance appropriate patients

Emre Çamur, Alper Coşkun, Ӧvünç Kavukoğlu, Utku Can, Önder Kara, Arzu Develi Çamur, Kemal Sarıca, Kamil Fehmi Narter

02-07-2019

https://doi.org/10.4081/aiua.2019.2.93

1477

Downloads: 901
MRI/US fusion prostate biopsy in men on active surveillance: Our experience

Vito Lacetera, Angelo Antezza, Alessio Papaveri, Emanuele Cappa, Bernardino Cervelli, Giuliana Gabrielloni, Michele Montesi, Roberto Morcellini, Gianni Parri, Emilio Recanatini, Valerio Beatrici

88-91

22-03-2021

https://doi.org/10.4081/aiua.2021.1.88

1538

Downloads: 882
Radical prostatectomy outcomes of prostate cancer cases: Insights from a leading surgeon's experience in Azerbaijan

Rashad Sholan

18-12-2024

https://doi.org/10.4081/aiua.2024.13257

1244

Downloads: 639
Evaluation of various active surveillance protocols in prostate cancer

Kayhan Yılmaz, Tahir Karadeniz, Orkunt Özkaptan, Oguz Yilanoglu

81-85

30-06-2014

https://doi.org/10.4081/aiua.2014.2.81

2072

Downloads: 1037
Primitive small cell carcinoma of the prostate. Case report and revision of the literature

Pietro Pepe, Ludovica Pepe, Mara Curdman, Michele Pennisi, Filippo Fraggetta

21-12-2020

https://doi.org/10.4081/aiua.2020.4.390

1370

Downloads: 821
MRI/TRUS FUSION guided biopsy as first approach in ambulatory setting: Feasibility and performance of a new fusion device

Daniele D'Agostino, Federico Mineo Bianchi, Daniele Romagnoli, Marco Giampaoli, Paolo Corsi, Alessandro Del Rosso, Riccardo Schiavina, Eugenio Brunocilla, Angelo Porreca

211-217

13-01-2020

https://doi.org/10.4081/aiua.2019.4.211

1689

Downloads: 917
Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature

Selcuk Sarıkaya, Mustafa Resorlu, Ural Oguz, Mustafa Yordam, Omer Faruk Bozkurt, Ali Unsal

288-290

30-12-2014

https://doi.org/10.4081/aiua.2014.4.288

3110

Downloads: 1820
Predictors of prostate cancer detection in MRI PI-RADS 3 lesions – Reality of a tertiary center

Débora Araújo, Alexandre Gromicho, Jorge Dias, Samuel Bastos, Rui Miguel Maciel, Ana Sabença, Luís Xambre

20-12-2023

https://doi.org/10.4081/aiua.2023.11830

4567

Downloads: 876
Are elevated mitochondrial DNA fragments in prostatic inflammation a potential biomarker for prostate cancer?

Ugur Aferin, Nurten Bahtiyar, Ilhan Onaran, Hamdi Ozkara

27-09-2023

https://doi.org/10.4081/aiua.2023.11610

1039

Downloads: 722
Transcutaneous perineal-ultrasound guided prostate biopsy in men with rectal amputation

Pietro Pepe, Ludovica Pepe, Vincenzo Fiorentino, Mara Curduman, Filippo Fraggetta

21-07-2025

https://doi.org/10.4081/aiua.2025.14047

678

Downloads: 570
Stereotactic Body Radiation Therapy (SBRT) for prostate cancer: Preliminary results of toxicity

Asmaa Naim, Safae Mansouri, Kamal Saidi, Abdeljalil Heddat, Younes Elhoury, Redouane Rabii

370-372

04-10-2021

https://doi.org/10.4081/aiua.2021.3.370

1172

Downloads: 813
Stereotactic radiotherapy in oligometastatic prostate cancer: a single-center experience

Ana Marta Ferreira, José Miguel Cunha, Edgar Tavares da Silva, Pedro Nunes, Arnaldo Figueiredo

29-05-2026

https://doi.org/10.4081/aiua.2026.15530

395

Downloads: 253
In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice

Amalia Katafigioti, Ioannis Katafigiotis, Stavros Sfoungaristos, Christos Alamanis, Konstantinos Stravodimos, Ioannis Anastasiou, Eleni Roumelioti, Mordechai Duvdevani, Constantinos Constantinides

195-200

05-10-2016

https://doi.org/10.4081/aiua.2016.3.195

3144

Downloads: 1675
10-year survival of a patient with metastatic prostate cancer: Case report and literature review

Kristian Krpina, Dean Markić, Dražen Rahelić, Juraj Ahel, Nino Rubinić, Josip Španjol

252-253

30-09-2015

https://doi.org/10.4081/aiua.2015.3.252

3507

Downloads: 1975
Diagnostic accuracy of the Novel 29 MHz micro-ultrasound “ExactVuTM” for the detection of clinically significant prostate cancer: A prospective single institutional study. A step forward in the diagnosis of prostate cancer

Francesco Chessa, Riccardo Schiavina, Amelio Ercolino, Caterina Gaudiano, Davide Giusti, Lorenzo Bianchi, Cristian Pultrone, Emanuela Marcelli, Concetta Distefano, Luca Lodigiani, Eugenio Brunocilla

132-138

28-06-2021

https://doi.org/10.4081/aiua.2021.2.132

2165

Downloads: 1642
Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsy

Pietro Pepe, Ludovica Pepe, Paolo Panella, Michele Pennisi

23-06-2020

https://doi.org/10.4081/aiua.2020.2.89

1808

Downloads: 1055
Effectiveness of cognitive fusion transrectal ultrasound prostate biopsy when compared with final prostatectomy histology

Ana Sofia Araújo, Joao Serra, Sara Anacleto, Ricardo Rodrigues, Catarina Tinoco, Andreia Cardoso, Mariana Capinha, Vera Marques, Paulo Mota

18-12-2024

https://doi.org/10.4081/aiua.2024.13194

1239

Downloads: 634
Salvage cryotherapy for prostate cancer

Duarte Vieira e Brito, Jose Alberto Pereira, Ana Maria Ferreira, Mario Lourenço, Ricardo Godinho, Bruno Pereira, Pedro Peralta, Paulo Conceiçao, Mario Reis, Carlos Rabaça

08-01-2024

https://doi.org/10.4081/aiua.2023.11897

883

Downloads: 712
Comparison between “In-bore” MRI guided prostate biopsy and standard ultrasound guided biopsy in the patient with suspicious prostate cancer: Preliminary results

Daniele D’Agostino, Federico Mineo Bianchi, Daniele Romagnoli, Paolo Corsi, Marco Giampaoli, Riccardo Schiavina, Eugenio Brunocilla, Walter Artibani, Angelo Porreca

02-07-2019

https://doi.org/10.4081/aiua.2019.2.87

2050

Downloads: 1036
Can perineural invasion detected in prostate needle biopsy specimens predict surgical margin positivity in D’Amico low risk patients?

Ozgur Haki Yuksel, Ahmet Urkmez, Ayhan Verit

89-92

04-07-2016

https://doi.org/10.4081/aiua.2016.2.89

1970

Downloads: 1060
The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL

Cem Yücel, Salih Budak, Erdem Kısa, Orcun Celik, Zafer Kozacıoglu

104-106

30-06-2018

https://doi.org/10.4081/aiua.2018.2.104

1760

Downloads: 801
Influence of antiplatelet-anticoagulant drugs on the need of blood components transfusion after vesical transurethral resection

Alvaro Julio Virseda-Rodríguez, Barbara Padilla-Fernández, Mirian López-Parra, Maria Tatiana Santos-Antunes, Lauro Sebastian Valverde-Martínez, Maria Jesus Nieto-González, Jesus Fernando San Miguel-Izquierdo, Anabel Lorenzo-Gómez, Maria Begoña García-Cenador, Patricia Antúnez-Plaza, Maria Fernanda Lorenzo-Gómez

136-140

07-07-2015

https://doi.org/10.4081/aiua.2015.2.136

2739

Downloads: 1550
Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: A comparative evaluation at the same Institution

Maria Angela Cerruto, Fabio Vianello, Carolina D’Elia, Walter Artibani, Giovanni Novella

284-287

30-12-2014

https://doi.org/10.4081/aiua.2014.4.284

4586

Downloads: 2153
Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy

Pietro Pepe, Antonio Garufi, Giandomenico Priolo, Giuseppe Dibenedetto, Michele Salemi, Michele Pennisi, Filippo Fraggetta, Francesco Aragona, Michele Barbera

336-339

30-12-2014

https://doi.org/10.4081/aiua.2014.4.336

2614

Downloads: 1789
Biopsy follow-up in patients with isolated atypical small acinar proliferation (ASAP) in prostate biopsy

Luca Leone, Vito Lacetera, Rodolfo Montironi, Ubaldo Cantoro, Alessandro Conti, Giulia Sbrollini, Luigi Quaresima, Luciana Mariani, Giovanni Muzzonigro, Andrea Benedetto Galosi

332-335

30-12-2014

https://doi.org/10.4081/aiua.2014.4.332

3359

Downloads: 1670
Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance

Roberta Mazzucchelli, Andrea Benedetto Galosi, Antonio Lopez-Beltran, Marina Scarpelli, Liang Cheng, Rodolfo Montironi

314-318

30-12-2014

https://doi.org/10.4081/aiua.2014.4.314

1892

Downloads: 1026
Evaluation of Tl-201 SPECT imaging findings in prostate cancer

Sinem Ozyurt, Gokhan Koca, Akif Diri, Koray Demirel, Tolga Karakan, Berkan Resorlu, Meliha Korkmaz, Cankon Germiyanoglu

147-150

07-07-2015

https://doi.org/10.4081/aiua.2015.2.147

2085

Downloads: 1595
Learning curve of a multidisciplinary team for magnetic resonance imaging/transperineal ultrasonography fusion prostate biopsy

Marcello Scarcia, Vincenzo Andracchio, Alberto Piana, Roberto Calbi, Michele Zazzara, Francesco Chiaradia, Antonio Greco, Flavio Sidoti, Gianluca Scarpelli, Pierluigi Rizzo, Guglielmo Mantica, Alessandro Calarco, Rosario Leonardi, Giuseppe Mario Ludovico, Stefano Alba

05-08-2025

https://doi.org/10.4081/aiua.2025.13933

562

Downloads: 616
Early functional and oncological outcomes after robot-assisted radical prostatectomy in D’Amico high-risk prostate cancer: a prospective cohort study

Jonathan Michel Keller, Mladen Stankovic, Teresa Wieder, Laura Wolff, Joao Mendes

25-09-2026

https://doi.org/10.4081/aiua.2026.15886

158

Downloads: 114
Detection limits of significant prostate cancer using multiparametric MR and digital rectal examination in men with low serum PSA: Up-date of the Italian Society of Integrated Diagnostic in Urology

Andrea B. Galosi, Erika Palagonia, Simone Scarcella, Alessia Cimadamore, Vito Lacetera, Rocco F. Delle Fave, Angelo Antezza, Lucio Dell'Atti

92-100

22-03-2021

https://doi.org/10.4081/aiua.2021.1.92

2544

Downloads: 1721
Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl

Volkan Caglayan, Efe Onen, Sinan Avci, Murat Sambel, Metin Kilic, Sedat Oner, Mustafa Murat Aydos, Halil Emre Yıldız

270-275

17-01-2019

https://doi.org/10.4081/aiua.2018.4.270

2837

Downloads: 1758
Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?

Senol Tonyali, Cavit Ceylan, Erdogan Aglamis, Serkan Dogan, Sedat Tastemur, Mustafa Karaaslan

31-34

18-03-2021

https://doi.org/10.4081/aiua.2021.1.31

1718

Downloads: 977
PSMA PET/CT in diagnosing and staging high grade prostate cancer: accuracy and cost-effectiveness

Pietro Pepe, Ludovica Pepe, Gabriele Pepe, Vincenzo Fiorentino

03-03-2026

https://doi.org/10.4081/aiua.2026.14797

574

Downloads: 491
Prostate-speciﬁc antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival

Alexandre Mendonça Macedo, Rita Gameiro Marques, Margarida Cunha André, Nuno Silva Figueira, Miguel Leal Carvalho

22-02-2023

https://doi.org/10.4081/aiua.2023.11052

1436

Downloads: 1156
Expression of miR-132 and miR-212 in prostate cancer and metastatic lymph node: Case report and revision of the literature

Michele Salemi, Angela Pettinato, Filippo Fraggetta, Aldo E. Calogero, Michele Pennisi, Ludovica Pepe, Pietro Pepe

01-10-2020

https://doi.org/10.4081/aiua.2020.3.209

1589

Downloads: 941
Prostate cancer with cribriform pattern: Exclusion criterion for active surveillance?

Rui Miguel Bernardino, Rita Carvalho, Luis Severo, Marta Alves, Ana Luisa Papoila, Luis Campos Pinheiro

02-10-2020

https://doi.org/10.4081/aiua.2020.3.235

1579

Downloads: 949
Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: A 12 months analysis after three consecutive prostate biopsies

Cosimo De Nunzio, Simone Albisinni, Antonio Cicione, Mauro Gacci, Costantino Leonardo, Francesco Esperto, Andrea Tubaro

59-64

24-06-2013

https://doi.org/10.4081/aiua.2013.2.59

2247

Downloads: 1850
Evaluation of the diagnostic and predictive power of PCA3 in the prostate cancer. A different best cut-off in each different scenario. Preliminary results

Giuseppe Albino, Ettore Capoluongo, Sandro Rocchetti, Sara Palumbo, Cecilia Zuppi, Ettore Cirillo-Marucco

306-310

30-12-2014

https://doi.org/10.4081/aiua.2014.4.306

2279

Downloads: 1333
Multidisciplinary approach to prostatitis

Vittorio Magri, Matteo Boltri, Tommaso Cai, Roberto Colombo, Salvatore Cuzzocrea, Pieter De Visschere, Rosanna Giuberti, Clara Maria Granatieri, Maria Agnese Latino, Gaetano Larganà, Christian Leli, Giorgio Maierna, Valentina Marchese, Elisabetta Massa, Alberto Matteelli, Emanuele Montanari, Giuseppe Morgia, Kurt G. Naber, Vaia Papadouli, Gianpaolo Perletti, Nektaria Rekleiti, Giorgio I. Russo, Alessandra Sensini, Konstantinos Stamatiou, Alberto Trinchieri, Florian M.E. Wagenlehner

227-248

18-01-2019

https://doi.org/10.4081/aiua.2018.4.227

28727

Downloads: 16540
Empiric antibiotics therapy for mildly elevated prostate specific antigen: Helpful to avoid unnecessary biopsies?

Andrea Fandella, Sara Benvenuto, Elisa Guidoni, Marco Giampaoli, Alessandro Bertaccini

202-204

30-09-2014

https://doi.org/10.4081/aiua.2014.3.202

2109

Downloads: 1393
Attitudes and perceptions towards multiparametric magnetic resonance imaging of the prostate: A national survey among Italian urologists

Arnaldo Stanzione, Massimiliano Creta, Massimo Imbriaco, Roberto La Rocca, Marco Capece, Fabio Esposito, Ciro Imbimbo, Ferdinando Fusco, Giuseppe Celentano, Luigi Napolitano, Francesco Mangiapia, Vincenzo Mirone, Nicola Longo

17-12-2020

https://doi.org/10.4081/aiua.2020.4.291

1436

Downloads: 709
Cost-effectiveness analysis of short biparametric magnetic resonance imaging protocol in men at risk of prostate cancer

Niccolò Faccioli, Elena Santi, Giovanni Foti, Pierpaolo Curti, Mirko D'Onofrio

160-165

29-06-2022

https://doi.org/10.4081/aiua.2022.2.160

1984

Downloads: 821
Beyond survival: addressing sexual health in advanced prostate cancer care

Aldo Franco De Rose, Sara Ciuffarella, Fabrizio Gallo, Guglielmo Mantica

29-07-2026

https://doi.org/10.4081/aiua.2026.15702

179

Downloads: 108
A comprehensive systematic review of studies on the potential of A49T and V89L polymorphism in SRD5AR2 as high susceptibility gene association with benign prostate hyperplasia and prostate cancer

Revina Maharani, Hotma Lestari, Putra Mahakarya Dewa, Dewangga Yudisthira, Nasim Amar, Besut Daryanto

17-02-2025

https://doi.org/10.4081/aiua.2025.13318

1434

Downloads: 727
Prostatic calculi detected in peripheral zone of the gland during a transrectal ultrasound biopsy can be significant predictors of prostate cancer

Lucio Dell’Atti, Andrea B. Galosi, Carmelo Ippolito

304-307

30-12-2016

https://doi.org/10.4081/aiua.2016.4.304

2713

Downloads: 2661
Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience

Nuno Dias, Lara Rodriguez-Sanchez, Gianmarco Colandrea, Petr Macek, Xavier Cathelineau

413-419

27-12-2022

https://doi.org/10.4081/aiua.2022.4.413

1215

Downloads: 854
Optimal clamping time in meatotomy procedure for children with meatal stenosis: Experience with 120 cases

Mehdi Shirazi, Umayir Chowdhury, Faisal Ahmed, Mohammad-Bagher Rajabalian, Hossein-Ali Nikbakht , Khalil Al-Naggar , Ebrahim Al-Shami

244-247

29-06-2021

https://doi.org/10.4081/aiua.2021.2.244

2066

Downloads: 944
Treatment outcome of Fournier's gangrene and its associated factors: A retrospective study

Khaled Al-Kohlany, Khaled Baker, Faisal Ahmed, Murtadha Mohamed, Majdi Alshami, Mohamed Badheeb

29-05-2023

https://doi.org/10.4081/aiua.2023.11318

1904

Downloads: 1008
The impact of inflammation on prostate tumor dynamics: a pathological perspective on prostate cancer and benign prostatic hyperplasia

Syakri Syahrir, Muhammad Asykar Palinrungi, Mochammad Hatta, Khoirul Kholis, Syarif Syarif, Abdul Azis, Muhammad Faruk

24-03-2025

https://doi.org/10.4081/aiua.2025.13353

1215

Downloads: 879
Minimal invasive percutaneous nephrolithotomy (Mini-PCNL) in children: Ultrasound versus fluoroscopic guidance

Ali Eslahi, Faisal Ahmed, Mohammad Mehdi Hosseini , Mohammad Reza Rezaeimehr, Nazanin Fathi, Hossein-Ali Nikbakht , Mohammad Reza Askarpour, Seyed Hossein Hosseini , Khalil Al-Naggar

173-177

28-06-2021

https://doi.org/10.4081/aiua.2021.2.173

2463

Downloads: 1082
A single-operator experience using EchoLaser SoracteLite^TM for focal laser ablation of prostate cancer: one more arrow in the quiver for the conservative management of the disease

Iacopo Meneghetti, Demostene Giardino, Riccardo Morganti, Vincenzo Marino, Filippo Menchini Fabris, Riccardo Bartoletti, Novello Pinzi

406-412

27-12-2022

https://doi.org/10.4081/aiua.2022.4.406

1462

Downloads: 856
Prognostic determinants and treatment outcomes of Fournier’s Gangrene treatment in a resource-limited setting: A retrospective study

Saif Ghabisha, Faisal Ahmed, Saleh Al-wageeh, Mohamed Badheeb, Qasem Alyhari, Abdulfattah Altam, Afaf Alsharif

25-07-2023

https://doi.org/10.4081/aiua.2023.11450

1439

Downloads: 850
Conﬁrmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassiﬁcation rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsy

Pietro Pepe, Ludovica Pepe, Michele Pennisi, Filippo Fraggetta

270-273

26-09-2022

https://doi.org/10.4081/aiua.2022.3.270

1905

Downloads: 723
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: Ultrasound feature in case report

Giulia Sbrollini, Alessandro Conti, Andrea Benedetto Galosi, Vito Lacetera, Rodolfo Montironi, Lorenzo Montesi, Giovanni Muzzonigro

393-394

30-12-2014

https://doi.org/10.4081/aiua.2014.4.393

1882

Downloads: 1685
Solitary prostatic cancer metastasis to the testis: A case report and lessons to learn

Asmaa Ismail, Hazem Elmansy, Walid Shahrour, Owen Prowse, Ahmed Kotb

265-266

14-01-2020

https://doi.org/10.4081/aiua.2019.4.265

1464

Downloads: 918
The role of immunotherapy in urological cancers

Efe Bosnali, Enes Malik Akdas, Engin Telli, Kerem Teke, Onder Kara

30-05-2024

https://doi.org/10.4081/aiua.2024.12307

2957

Downloads: 1843
BRCA mutations and prostate cancer: should urologist improve daily clinical practice?

Simona Vatrano, Pietro Pepe, Ludovica Pepe, Nuccia Vella, Cristina Alario, Alessia Chiarandà, Chiara Taranto, Renato Scillieri, Cristina Mauceri, Filippo Fraggetta

17-04-2025

https://doi.org/10.4081/aiua.2025.13635

2116

Downloads: 930
Should pathologists and clinicians continue to consider Grade Group 1 (Gleason score ≤6) prostate cancer as a true carcinoma? Let’s hear from patient advocates

Rodolfo Montironi, Alessia Cimadamore, Antonio Lopez-Beltran, Eamonn T. Rogers, Liang Cheng

10-06-2025

https://doi.org/10.4081/aiua.2025.13925

728

Downloads: 492
Expression and diagnostic potential of circulating miR-107, miR-134-5p, miR-149-5p, miR-370-3p, and miR-221 in prostate cancer and benign prostatic hyperplasia: a preliminary study

Ali Akkoç, Hamiyet Eciroglu Sarban, Fatma Yildiz, Ozlem Ceren Gunizi, Murat Ucar

18-11-2025

https://doi.org/10.4081/aiua.2025.14585

766

Downloads: 398
The association between prostatitis and prostate cancer. Systematic review and meta-analysis

Gianpaolo Perletti, Elena Monti, Vittorio Magri, Tommaso Cai, Anne Cleves, Alberto Trinchieri, Emanuele Montanari

259-265

31-12-2017

https://doi.org/10.4081/aiua.2017.4.259

5666

Downloads: 2328
The effect of flavonoid and subclasses supplementation on prostate specific antigen, hormonal parameters and prostate cancer risk: a systematic review and meta-analysis of randomized controlled trials

Abdul Azis, Andi Asadul Islam, Haerani Rasyid, Lukman Hakim, Syakib Bakri, Agussalim Bukhari, Andi Alfian Zainuddin

17-04-2025

https://doi.org/10.4081/aiua.2025.13645

1669

Downloads: 2400

1 - 100 of 197 items 1 2 > >>

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.